Avanos Medical, Inc. (NYSE:AVNS) Stake Lowered by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC reduced its stake in shares of Avanos Medical, Inc. (NYSE:AVNS) by 21.0% during the 4th quarter, HoldingsChannel reports. The fund owned 3,329 shares of the company’s stock after selling 887 shares during the period. Nisa Investment Advisors LLC’s holdings in Avanos Medical were worth $75,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Credit Suisse AG grew its holdings in shares of Avanos Medical by 1.0% during the 3rd quarter. Credit Suisse AG now owns 44,203 shares of the company’s stock valued at $964,000 after acquiring an additional 458 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Avanos Medical by 2.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 20,722 shares of the company’s stock valued at $419,000 after acquiring an additional 504 shares in the last quarter. Captrust Financial Advisors grew its holdings in shares of Avanos Medical by 23.9% during the 1st quarter. Captrust Financial Advisors now owns 2,704 shares of the company’s stock valued at $91,000 after acquiring an additional 521 shares in the last quarter. Lazard Asset Management LLC grew its holdings in shares of Avanos Medical by 10.2% during the 4th quarter. Lazard Asset Management LLC now owns 6,225 shares of the company’s stock valued at $168,000 after acquiring an additional 575 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky grew its holdings in shares of Avanos Medical by 5.6% during the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 15,456 shares of the company’s stock valued at $395,000 after acquiring an additional 816 shares in the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Avanos Medical from a “hold” rating to a “buy” rating in a report on Tuesday, March 19th.

Avanos Medical Stock Up 0.1 %

AVNS stock opened at $18.71 on Friday. The company has a current ratio of 2.08, a quick ratio of 1.38 and a debt-to-equity ratio of 0.13. Avanos Medical, Inc. has a 1 year low of $17.24 and a 1 year high of $31.31. The company has a fifty day simple moving average of $19.31 and a 200 day simple moving average of $19.95. The firm has a market cap of $864.46 million, a PE ratio of -14.17, a PEG ratio of 1.09 and a beta of 0.96.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Tuesday, February 20th. The company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.01). Avanos Medical had a negative net margin of 8.76% and a positive return on equity of 4.25%. The business had revenue of $173.30 million during the quarter, compared to analyst estimates of $170.43 million. During the same period in the previous year, the firm posted $0.60 EPS. The firm’s revenue for the quarter was down 4.6% on a year-over-year basis. Sell-side analysts anticipate that Avanos Medical, Inc. will post 1.38 EPS for the current fiscal year.

Insider Activity at Avanos Medical

In related news, CFO Michael Greiner sold 8,000 shares of Avanos Medical stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $19.12, for a total value of $152,960.00. Following the completion of the sale, the chief financial officer now owns 151,495 shares of the company’s stock, valued at approximately $2,896,584.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.90% of the stock is owned by company insiders.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.